Literature DB >> 29396075

Beasley's 1981 paper: The power of a well-designed cohort study to drive liver cancer research and prevention.

Jill Koshiol1, Zhiwei Liu2, Thomas R O'Brien2, Allan Hildesheim2.   

Abstract

The 1981 Lancet paper by Beasley et al., "Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan" is a seminal publication that clearly demonstrated that chronic infection with hepatitis B virus (HBV), as measured by seropositivity for the hepatitis B surface antigen (HBsAg), preceded the development of hepatocellular carcinoma (HCC). In doing so, this study paved the way for liver cancer prevention efforts through the implementation of hepatitis B vaccination programs. In this commentary, we will describe the discovery of HBV, which led to the study by Beasley et al.; summarize the major findings of the Beasley paper and its implications; discuss the importance of well-designed cohort studies for prevention activities; and consider the ramifications of the Beasley study and the work that has followed since. Published by Elsevier Ltd.

Entities:  

Keywords:  Aflatoxin; HBV Vaccination; Hepatitis B infection; Hepatocellular carcinoma; Liver cancer

Mesh:

Substances:

Year:  2018        PMID: 29396075      PMCID: PMC5866222          DOI: 10.1016/j.canep.2018.01.007

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  48 in total

1.  Effectiveness of a middle school vaccination law--California, 1999-2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-08-10       Impact factor: 17.586

Review 2.  Then and now: the progress in hepatitis B treatment over the past 20 years.

Authors:  Dina Halegoua-De Marzio; Hie-Won Hann
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

3.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

4.  Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma.

Authors:  P Maupas; B Werner; B Larouzé; I Millman; W T London; A O'Connell; B S Blumberg
Journal:  Lancet       Date:  1975-07-05       Impact factor: 79.321

5.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Authors:  Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis
Journal:  Int J Epidemiol       Date:  2005-10-25       Impact factor: 7.196

6.  The global health burden of infection-associated cancers in the year 2002.

Authors:  Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

7.  Vaccine against human hepatitis B.

Authors:  E B Buynak; R R Roehm; A A Tytell; A U Bertland; G P Lampson; M R Hilleman
Journal:  JAMA       Date:  1976-06-28       Impact factor: 56.272

8.  Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer.

Authors:  Mei-Hwei Chang; San-Lin You; Chien-Jen Chen; Chun-Jen Liu; Ming-Wei Lai; Tzee-Chung Wu; Shu-Fen Wu; Chuan-Mo Lee; Sheng-Shun Yang; Heng-Cheng Chu; Tsang-Eng Wang; Bor-Wen Chen; Wan-Long Chuang; Maw-Soan Soon; Ching-Yih Lin; Shu-Ti Chiou; Hsu-Sung Kuo; Ding-Shinn Chen
Journal:  Gastroenterology       Date:  2016-06-04       Impact factor: 22.682

Review 9.  A brief history of hepatitis milestones.

Authors:  Christian Trepo
Journal:  Liver Int       Date:  2014-02       Impact factor: 5.828

Review 10.  Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks.

Authors:  Patrick T F Kennedy; Samuel Litwin; Grace E Dolman; Antonio Bertoletti; William S Mason
Journal:  Viruses       Date:  2017-04-29       Impact factor: 5.048

View more
  2 in total

1.  Hepatitis C virus and hepatitis B virus in patients with schizophrenia.

Authors:  Chun-Hung Chang; Chieh-Yu Liu; Shaw-Ji Chen; Hsin-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 2.  Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.

Authors:  Daniela Bender; Eberhard Hildt
Journal:  Int J Mol Sci       Date:  2019-09-19       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.